Cytal™ Wound Matrix (1-Layer, 2-Layer, 3-Layer, 6-Layer)

Cytal™ Wound Matrix is a sterile, porcine-derived, naturally-occurring lyophilized extracellular matrix in sheet form that maintains and supports a healing environment for wound management.

Integra LifeSciences Corp.

 Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery and reconstructive and general surgery.
Toll free:(800) 654-2873 Fax:(888) 980-7742 Website: www.integralife.com
Benefits

• Maintains and supports a healing environment through constructive remodeling
• Comprised of naturally-occurring urinary bladder matrix
• Contains basement membrane and numerous collagens
• Maintains an intact epithelial basement membrane
• Non-crosslinked wound management scaffold
• Appropriate for acute and chronic wounds
• Complements standard of care
• Fenestrated sheets

Indications

Cytal™ Wound Matrix is intended for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. This device is intended for one-time use.

Contraindications

Contraindicated for use on patients with known sensitivity or allergy to porcine materials and third-degree burns.

Warnings and Precautions

Cytal™ Wound Matrix is intended for one-time use. Do not re-use or sterilize. Do not use if package seal has been broken. Complications and reactions are possible with any soft tissue repair, including but not limited to: infection, increased chronic inflammation, allergic reaction, unexplained fever or chills, excessive redness, pain or swelling.

Storage Requirements

Store in a clean, dry environment between 15°C-35°C (59°F-95°F) in unopened and undamaged package.

How Supplied/Sizing
3cmx3(1/2)cm to 10cmx15cm.
HCPCS Code
Product features
check_circle Assigned HCPCS code
cancel Minimally manipulated
cancel Dehydrated
cancel Desiccated
cancel Flowable
cancel Micronized
check_circle Sheet form
cancel Requires refrigeration
cancel Shelf life greater than 2 years
cancel Shelf life limited
check_circle Indicated for acute wounds
check_circle Indicated for chronic wounds
check_circle Indicated for diabetic ulcers
check_circle Indicated for pressure ulcers
cancel Indicated for second-degree burns
check_circle Indicated for surgical wounds
cancel Indicated for third-degree burns
check_circle Indicated for venous ulcers
cancel Contact manufacturer for usage guidelines
Other features
check_circle Educational Material Available
check_circle Free Samples/Trials Available
check_circle Published Clinical Article Available
Recommended Use

Chronic Wounds
Diabetic Foot
Pressure Ulcers
Superficial Wounds
Surgical Wounds
Venous Ulcers

Mode of Use/Application

Clean wound bed by removing necrotic tissue and scar tissue to obtain fresh tissue edges. Irrigate excessive exudates and control bleeding. Remove Cytal™ Wound Matrix from container using standard aseptic methods. Cut device slightly bigger than area of wound to be covered. Rehydrate Cytal™ Wound Matrix in room temperature sterile saline or sterile lactated Ringer's solution in a sterile dish for five minutes prior to use.

Large wound: More than one device may be needed to cover wound area. Overlap Cytal™ Wound Matrix edges slightly to ensure complete coverage.

Wet wound: Cover device with non-adherent dressing such as petrolatum gauze, followed by application of an absorptive dressing such as a calcium alginate. Secure dressings to wound site.

Dry wound: The non-adherent dressing should be followed by application of a hydrogel dressing to keep wound moist. Secure dressings to wound site. Keep device and wound bed moist.

Removal & Change Frequency

Inspect wound for adverse reactions every seven days; remove exudates and apply new Cytal™ Wound Matrix to any non-covered wound areas. Do not remove any remaining device that is intact on wound surface. As Cytal™ Wound Matrix is resorbed, it may form a caramel-colored gel. Rinse wound surface gently leaving the caramel-colored gel intact and reapply another device. Repeat wound care follow-up process weekly until wound has epithelialized. Monitor tissue surrounding edges of wound.

No posters match your selected filters. Remove some filtres, or reset them and start again.

Have a product to submit?

Be included in the most comprehensive wound care products directory
and online database.
Learn More

Submit your products